Thonzylamine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H22N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R79646H5Z8, chemically known as pyrimidine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)- but generally known as thonzylamine, which bears US NIH Compound Identifier 5457. European Medicines Agency schedules Thonzylamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10988MIG. The term THONZYLAMINE is an International Non-Proprietary Name. World Health Organization schedules thonzylamine in its Anatomical Therapeutic Chemical (ATC) Classification. THONZYLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thonzylamine under HS 29335995 and SITC 51576. As of Q4 2014, THONZYLAMINE remains the US FDA Preferred Term for this commodity. Thonzylamine bears US NLM identifiers UMLS ID C0175162 and NCI Concept Code C84204. SMILES: O(C1CCC(CN(CCN(C)C)C2NCCCN2)CC1)C.